NBC News - Hemp industry expected to blossom under new Farm

New Post Public Reply Private Reply Replies (0) Message Board
StanleyK
1,293
NBC News - Hemp industry expected to blossom under new Farm Bill

"This is a cultural shift," said one purveyor of cannabidiol, CBD, a compound derived from hemp.

The U.S. hemp industry is expecting business to expand and investors to beckon after Congress on Wednesday passed farm legislation that included a provision to legalize and regulate the plant under the Department of Agriculture.

"This is a monumental bill for hemp farming," said Lauren Stansbury of the Hemp Industries Association.

The bill, awaiting President Trump's signature, opens the door to state-by-state regulation, removes hemp, which is part of the cannabis plant family, from the federal enforcement of outlaw drugs and gives hemp farmers access to banking, crop insurance and federal grants, experts said.

That could open the industry, which produces therapeutic cannabidiol (CBD), fabric, rope and even ethanol, to a wave of investment.

"This is a cultural shift," said Bomi Joseph, creator of CBD product ImmunAG. "CBD is going to explode. I think the market is going to triple in size."

Cannabidiol has been touted as an elixir that can do everything from cure cancer to tame menstrual cramps, but so far the U.S. Food and Drug administration has only approved a specific formulation of CBD to treat seizures associated with rare forms of epilepsy.

The bill "puts forth a whole-plant definition of hemp including extracts," said Stansbury of the Hemp Industries Association. "We’re not just talking stalk or flower. Any product derived from hemp is a legal consumer product."

But for now at least the FDA could stand in the way.

It states that CBD products can't be sold as dietary supplements and that those making medical claims are illegal without its approval. However, the FDA aims its most serious enforcement efforts at products "marketed for serious or life threatening diseases," according to a statement.

And the dietary supplement exclusion could be revisited, the administration has stated. "The FDA could allow it to be regulated as food and dietary supplements," said Shawn Hauser of the Colorado law firm Vicente Sederberg, which worked on the hemp legislation.

Under the bill, CBD products derived from hemp and containing 0.3 percent or less of the high-inducing cannabinoid THC will be considered legitimate.

"It would no longer be controlled under the DEA's purview," said U.S. Drug Enforcement Administration spokeswoman Mary Brandenberger.

Cannabis market data firm New Frontier recently projected that the American CBD market could reach $2.3 billion in revenues by 2022. Hemp-derived CBD (it can also come from other forms of cannabis) was expected to be worth more than half that total.

"The recent Farm Bill will have significant impacts on this channel as companies begin moving into mass market retailers now that hemp will be removed from the Controlled Substances Act," Nick Olsen, a spokesman for New Frontier, said via email.

The organization Vote Hemp said in summer that U.S. revenues for the total plant in 2017 were at a little more than $800 annually and growing.

Now hemp enthusiasts expect to see more CBD and hemp-derived products at mass market retailers in the months and years to come. "This bill will make hemp explode," said Erica McBride, executive director of the National Hemp Association.

The legislation will also allow transportation across state lines, academic research, production on tribal lands, and state regulation, including prohibition. In fact, experts expect it to take about a year for states to work out their own regulations or allow federal law to supersede.

They said about 40 states already had some form of hemp pilot program. U.S. Senate Majority Leader Mitch McConnell (R-KY) backed the hemp provision vociferously, saying that a pilot program in his own home state has "become a booming success."

"Its uses range from food and pharmaceuticals to home insulation and automotive parts," he said in a statement. "Enthusiastic farmers quickly applied to plant the crop in their fields. Entrepreneurs opened businesses selling hemp-based products. And consumers got to enjoy a whole new set of goods featuring American-made hemp."

Not everyone is so excited.

The Drug Policy Alliance, one of the nation's most potent champions for cannabis legalization, didn't take a position on the farm bill. The group tried to strike language that prohibits folks with drug convictions from working in the industry for 10 years.

"We’re not celebrating," said Grant Smith, the alliance's deputy director of national affairs. "For people who have a recent conviction it's essentially a de facto ban."

"There’s all this talk of criminal justice reform and here we have this brand new legalized industry that could create a lot of new jobs in areas where they're badly needed," he said. "They're going to be deterred from contributing to our economy. It doesn't make any sense."

Source...
Dec. 16, 2018 / 3:13 PM EST
By Dennis Romero

Hemp, Inc. (HEMP) Stock Research Links

HEMP Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 20

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 15

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 28

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 29

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 21

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 25

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 29

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading

Top 5 Most Recently Viewed Articles

S&T Bank's Commitment Shines with $20,000 Donation to Hospital

Updated Category News Views 74

S&T Bank’s Charitable Contributions to Health Initiatives S&T Bank is thrilled to announce a generous $20,000 donation to UPMC Children's Hospital, marking the second straight year they’ve provided this essential support. As a subsidiary of S&T Bancorp Inc. (NASDAQ: STBA), S&T Bank is dedicated to positively impacting the community, especially through initiatives that...

Continue Reading
Victor Turcanu Enhances Tannenbaum Helpern's Franchising Team

Updated Category News Views 124

Victor Turcanu Joins Tannenbaum Helpern Tannenbaum Helpern is excited to announce that Victor Turcanu has joined the firm as an associate in its Distribution, Franchising, and E-Commerce practice. With a wealth of experience as a franchise attorney and insights gained from his previous practices in Canada, Victor brings invaluable expertise in both domestic and...

Continue Reading
Director Boosts Stake in York Water Co with $999 Purchase

Updated Category News Views 53

Director Expands Stake in York Water Co In a notable move, Steven R. Rasmussen, a director at York Water Co (NASDAQ:YORW), has ramped up his investment by acquiring shares worth $999. This purchase, which involved 25.551 shares at a price of $39.137 each, signals his dedication to the company's future. The timing of this transaction underscores his confidence in the...

Continue Reading
MGID Welcomes New Leaders to Enhance Global Advertising Space

Updated Category News Views 83

MGID Expands Senior Leadership Team MGID, a global leader in the advertising space, has recently made significant strides in enhancing its senior leadership team. With the onboarding of Alex Distadio as Regional Head of Publisher Acquisition for the Americas and Ela Krief as Global Head of Account Management, the company is poised to elevate its service capabilities while...

Continue Reading
Unisys Prepares for Upcoming Third-Quarter Financial Review

Updated Category News Views 97

Unisys Prepares for Upcoming Financial Overview Unisys (NYSE: UIS) is gearing up to release its financial results for the third quarter of 2024, marking an important moment for stakeholders and investors. The company plans to unveil these results on a specific Tuesday afternoon after the stock market closes. This regular update is a vital part of Unisys' commitment to...

Continue Reading